ATE449162T1 - Herstellung von tcr gamma delta t-zellen - Google Patents

Herstellung von tcr gamma delta t-zellen

Info

Publication number
ATE449162T1
ATE449162T1 AT01921047T AT01921047T ATE449162T1 AT E449162 T1 ATE449162 T1 AT E449162T1 AT 01921047 T AT01921047 T AT 01921047T AT 01921047 T AT01921047 T AT 01921047T AT E449162 T1 ATE449162 T1 AT E449162T1
Authority
AT
Austria
Prior art keywords
cells
gamma delta
tcr gamma
production
growth factors
Prior art date
Application number
AT01921047T
Other languages
English (en)
Inventor
David Bell
Danna Skea
Original Assignee
Therapure Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapure Biopharma Inc filed Critical Therapure Biopharma Inc
Application granted granted Critical
Publication of ATE449162T1 publication Critical patent/ATE449162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT01921047T 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen ATE449162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19403300P 2000-04-03 2000-04-03
PCT/CA2001/000444 WO2001075072A2 (en) 2000-04-03 2001-04-03 PRODUCTION OF TcR GAMMA DELTA T CELLS

Publications (1)

Publication Number Publication Date
ATE449162T1 true ATE449162T1 (de) 2009-12-15

Family

ID=22716029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01921047T ATE449162T1 (de) 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen

Country Status (9)

Country Link
EP (1) EP1268746B1 (de)
JP (1) JP4982645B2 (de)
AT (1) ATE449162T1 (de)
AU (2) AU2001248162B2 (de)
CA (1) CA2405050C (de)
DE (1) DE60140526D1 (de)
ES (1) ES2336302T3 (de)
NZ (1) NZ522337A (de)
WO (1) WO2001075072A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2629532C (en) 2005-11-18 2016-08-09 University Health Network Method of expanding double negative t cells
MX2009001269A (es) 2006-08-01 2009-03-26 Arigen Pharmaceuticals Inc Metodo de proliferacion de celulas asesinas activadas por linfocina.
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
CA2954546A1 (en) * 2014-07-09 2016-01-14 Tc Biopharm Ltd Gamma delta t cells and uses thereof
GB201507368D0 (en) 2015-04-30 2015-06-17 Ucl Business Plc Cell
PL3307875T3 (pl) 2015-06-09 2022-08-01 Lymphact - Lymphocyte Activation Technologies, S.A. Sposoby wytwarzania limfocytów t tcr gamma delta+
EP3623468A1 (de) 2015-06-09 2020-03-18 Lymphact - Lymphocyte Activation Technologies, S.A. Verfahren zur herstellung von tcr-gamma-delta+-t-zellen
JP6621171B2 (ja) * 2015-06-22 2019-12-18 国立大学法人広島大学 Ｔ細胞活性化剤、ｔ細胞の活性化方法、および、ｔ細胞培養用培地
JP7479635B2 (ja) 2018-07-13 2024-05-09 国立大学法人京都大学 γδＴ細胞の製造方法
BR112022009181A2 (pt) 2019-11-25 2022-07-26 Univ Kyoto Sistema para prover um produto de célula t, métodos para produzir um produto de célula t, para construir um banco celular e uma coleção de produto de célula t e para prover um produto de célula t, banco celular, coleções de banco celular e de produto de célula t, e, produto de célula t
US20230117388A1 (en) * 2021-10-20 2023-04-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for expanding tumor infiltrating gamma-delta t cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033891A1 (en) * 1997-01-31 1998-08-06 Hemosol Inc. Method for the production of selected lymphocytes
JPH10295368A (ja) * 1997-04-22 1998-11-10 Hitachi Chem Co Ltd ガンマー・デルタｔ細胞の製造法及び免疫治療剤
EP1062320A4 (de) * 1998-03-12 2003-01-02 Univ Emory Methoden und zusammensetzungen für die selektive ausbreitung von gamma/delta t-zellen
ES2319942T3 (es) * 1998-11-04 2009-05-14 Therapure Biopharma Inc. Procedimientos para la produccion de celulas t tcr gamma delta.

Also Published As

Publication number Publication date
NZ522337A (en) 2004-12-24
AU4816201A (en) 2001-10-15
WO2001075072A3 (en) 2002-04-25
JP4982645B2 (ja) 2012-07-25
CA2405050A1 (en) 2001-10-11
WO2001075072A2 (en) 2001-10-11
EP1268746B1 (de) 2009-11-18
ES2336302T3 (es) 2010-04-12
CA2405050C (en) 2010-06-15
DE60140526D1 (de) 2009-12-31
EP1268746A2 (de) 2003-01-02
JP2003529363A (ja) 2003-10-07
AU2001248162B2 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
ATE408004T1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
CA2058930A1 (en) Media for cell growth and method for making them
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
WO2002066603A3 (en) Chemically defined medium for cultured mammalian cells
ATE414782T1 (de) Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen
ES2120946T3 (es) Sistemas y medios de cultivo celular.
WO2003089567A3 (en) Apparatus and method for a cell culture in a bioreactor at high cell concentration
AR000921A1 (es) Composicion como medio de cultivo para soportar el crecimiento de poblaciones celulares. metodo in vitro para sostener el crecimiento in vitro dede celulas eucarioticas, respectivamente para in vitro incrementar las propiedades del tejido submucoso para cultivar celulas islote o analizar in
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
AU4017501A (en) Cell culture spinner flasks
DE69735059D1 (de) Erhöhte produktion von taxanen durch zellkulturen von taxus-arten
ATE421573T1 (de) Verfahren zur herstellung von gamma delta t zellen
DK1292672T3 (da) Immobiliseringsbærer omfattende et poröst medium
TR200001960T2 (tr) Biyolojik ürünlerin üretimi için hücrelerin hazırlanması.
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
RU2009149159A (ru) Способы предотвращения глюконилирования белков
DE602006014534D1 (de) Herstellung und verwendung von basalmembranpartikeln
DK0651788T3 (da) Fremgangsmåde til dyrkning af en celletype i en cokulturfremgangsmåde med leverceller
ATE290067T1 (de) Verfahren zur erhöhung der wachstumsrate von zellen in statischen flüssigmedien
DE69014723D1 (de) Zellzüchtungsverfahren.
DE69923595D1 (de) Herstellung von proteinen
KR830001367A (ko) 열에 안정한 글루코아밀라제의 제법
KR910012253A (ko) 폴리-3-히드록시부티르산의 생합성 방법
KR910001053A (ko) 형질전환된 효모를 이용하여 외래 단백질을 고농도로 생산하는 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties